Facilitators and Barriers to Cancer Treatment Among Texas Residents

NCT07105046 | Not Yet Recruiting DMC

• 2 other identifiers: 2025-0697NCI-2025-05584
• Study Type: interventional
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

This trial uses semi-structured interviews and focus groups to determine facilitators and barriers of receiving timely cancer treatment among multiple cancers, across multiple insurance types, throughout Texas

Conditions

Cancer

Outcome Measures

Primary Outcomes (1)

• 1. Safety and Adverse Events (AEs)

  Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

  Through study completion; an average of 1 year

Study Arms (2)

Semi-structured Interview

EXPERIMENTAL

Participants will be recruited through the Texas Cancer Registry (TCR).

Other: Focus Groups

Online Focus Group

EXPERIMENTAL

Participants will be recruited through the Texas Cancer Registry (TCR).

Other: Interviews

Interventions

Interviews OTHER

A 30 to 45-minute in-depth semi-structured interview by phone will be administer, following a semi-structured interview guide.

Online Focus Group

Focus Groups OTHER

45 to 60 minutes video conference

Semi-structured Interview

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Aims 1 and 2
• In order to be eligible to participate in this study, an individual must meet all of the following criteria:
• Verbal consent will be obtained
• Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study
• Males and females; Age ≥ 18 years old
• Documented diagnosis of breast, colorectal, lung, and prostate cancer patients, stage I-IV
• Either English or Spanish-speaking

You may not qualify if:

• Aims 1 and 2
• An individual who meets any of the following criteria will be excluded from participation in this study:
• Patients who are cognitively impaired
• Pregnant women

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (1)

The University of Texas M. D. Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• MD Anderson Cancer Center Website

MeSH Terms

Conditions

Neoplasms

Interventions

Interviews as Topic; Focus Groups

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• John Lin, MD

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Central Study Contacts

John Lin, MD

CONTACT

(832) 729-0382; jlin11@mdanderson.org

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 29, 2025
• First Posted: August 5, 2025
• Study Start: January 31, 2026
• Primary Completion (Estimated): December 31, 2026
• Study Completion (Estimated): December 31, 2028
• Last Updated: March 2, 2026

Record last verified: 2026-02

Locations

US (1)